EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib

Giordana Feriotto iD, Paolo Marchetti, Riccardo Rondanin, Federico Tagliati, Serena Aguzzi iD, Simone Beninati iD, Fabio Casciano iD, Claudio Tabolacci iD, Carlo Mischiati iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Giordana Feriotto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Curcumin, Antineoplastic Agents, Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite curcumin (CUR) inhibiting cell proliferation in vitro by activating apoptotic cell death, its use in pharmacological therapy is hampered by poor solubility, low stability in biological fluids, and rapid removal from the body. Therefore, CUR-derivatives with better biological and chemical–physical characteristics are needed. The bis-ketone moiety of CUR strongly influences its stability in slightly alkaline solutions such as plasma. Here, we considered its replacement with isoxazole, beta-enamine, or oxime groups to obtain more stable derivatives. The evaluation of the chemical–physical characteristics showed that only of the isoxazole derivatives 2 and 22 had better potential than CUR in terms of bioavailability. The UV–visible spectrum analysis showed that derivatives 2 and 22 had better stability than CUR in solutions mimicking the biological fluids. When tested on a panel of cell lines, derivatives 2 and 22 had marked cytotoxicity (IC50 = 0.5 µM) compared with CUR only (IC50 = 17 µM) in the chronic myeloid leukemia (CML)-derived K562 cell line. The derivative 22 was the more selective for CML cells. When administered at the average concentration found for CUR in the blood of patients, derivatives 2 and 22 had potent effects on cell cycle progression and apoptosis initiation, while CUR was ineffective. The apoptotic effect of derivatives 2 and 22 was associated with low necrosis. In addition, derivative 22 was able to reverse drug resistance in K562 cells resistant to imatinib (IM), the reference drug used in CML therapy. The cytotoxicity of derivative 22 on IM-sensitive and resistant cells was associated with upregulation of FOXN3 and CDKN1A expression, G2/M arrest, and triggering of apoptosis. In conclusion, derivative 22 has chemical–physical characteristics and biological effects superior to CUR, which allow us to hypothesize its future use in the therapy of CML and CML forms resistant to IM, either alone or in combination with this drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminAntineoplastic AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansImatinib MesylateK562 CellsApoptosisDrug Resistance, NeoplasmCell Line, TumorG2 Phase Cell Cycle Checkpoints

Stichwörter der Autor:innen

CMLapoptosiscurcuminderivativesimatinib

Substanzen

Imatinib MesylateCurcuminAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.

ORCID-Profile: Giordana Feriotto, Serena Aguzzi, Simone Beninati, Fabio Casciano, Claudio Tabolacci, Carlo Mischiati

Zitieren

APA

Feriotto, G., Marchetti, P., Rondanin, R., Tagliati, F., Aguzzi, S., Beninati, S., Casciano, F., Tabolacci, C., & Mischiati, C. (2023). Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032356

Vancouver

Feriotto G, Marchetti P, Rondanin R, Tagliati F, Aguzzi S, Beninati S, et al. Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032356

BibTeX
@article{Feriotto2023,
  author = {Feriotto, Giordana and Marchetti, Paolo and Rondanin, Riccardo and Tagliati, Federico and Aguzzi, Serena and Beninati, Simone and Casciano, Fabio and Tabolacci, Claudio and Mischiati, Carlo},
  title = {Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032356}
}
Kostenlos starten →